LECAP Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,547
Closed -$1.22M 336
2026
Q1
$1.22M Sell
2,547
-1,235
-33% -$632K 0.46% 86
2025
Q4
$2.12M Buy
+3,782
New +$2.15M 0.85% 14
2024
Q4
Sell
-10,119
Closed -$3.38M 358
2024
Q3
$3.38M Buy
10,119
+5,238
+107% +$1.99M 0.73% 27
2024
Q2
$2.01M Buy
+4,881
New +$1.93M 0.43% 83

Other funds holding MEDP

LECAP Asset Management's MEDP Position: Q2 2026 in Review

LECAP Asset Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 2,547 shares — an estimated $1.22M sold.

LECAP Asset Management first reported a position in MEDP in Q2 2024 and held it in 4 quarters. The position peaked at $3.38M in Q3 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • LECAP Asset Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • LECAP Asset Management sold 2,547 Medpace shares in Q2 2026, an estimated $1.22M.
  • LECAP Asset Management first reported a position in Medpace in Q2 2024 and held it in 4 quarters.
  • LECAP Asset Management's Medpace position peaked at $3.38M in Q3 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.